NCT03076554

A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2017-04-19Est. Completion: 2026-06-30

Enrollment target: 56 participants

Locations

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

ThymomaStomach NeoplasmsPancreatic NeoplasmsMesotheliomaBiliary Tract NeoplasmsMesothelin Expressing Neoplasms

Background: * Malignant mesothelioma is a malignancy arising from the mesothelial cells of the pleura, peritoneum, peri…

Bethesda, United StatesEst. completion Jul 25, 2033

MesotheliomaNeoplasmsStomach NeoplasmsPancreatic Neoplasms

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.